HEADER SIGNALING PROTEIN 03-JUL-23 8PO4
TITLE DISCOVERY AND OPTIMISATION OF POTENT, EFFICACIOUS AND SELECTIVE
TITLE 2 INHIBITORS TARGETING EGFR EXON20 INSERTION MUTATIONS. COMPOUND 33
TITLE 3 BOUND TO EGFR[V948R]
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: EPIDERMAL GROWTH FACTOR RECEPTOR;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: PROTO-ONCOGENE C-ERBB-1,RECEPTOR TYROSINE-PROTEIN KINASE
COMPND 5 ERBB-1;
COMPND 6 EC: 2.7.10.1;
COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: EGFR, ERBB, ERBB1, HER1;
SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108
KEYWDS EGFR, EXON 20 INSERTION, NON-SMALL CELL LUNG CANCER, ONCOLOGY,
KEYWDS 2 SIGNALING PROTEIN
EXPDTA X-RAY DIFFRACTION
AUTHOR D.HARGREAVES
REVDAT 3 20-NOV-24 8PO4 1 REMARK
REVDAT 2 19-JUN-24 8PO4 1 JRNL
REVDAT 1 05-JUN-24 8PO4 0
JRNL AUTH C.THOMSON,P.BARTON,E.BRAYBROOKE,N.COLCLOUGH,Z.DONG,L.EVANS,
JRNL AUTH 2 N.FLOC'H,C.GUEROT,D.HARGREAVES,P.KHURANA,S.LI,X.LI,A.LISTER,
JRNL AUTH 3 W.MCCOULL,L.MCWILLIAMS,J.P.ORME,M.J.PACKER,A.M.SWAIH,
JRNL AUTH 4 R.A.WARD,P.WINLOW,Y.YE
JRNL TITL DISCOVERY AND OPTIMIZATION OF POTENT, EFFICACIOUS AND
JRNL TITL 2 SELECTIVE INHIBITORS TARGETING EGFR EXON20 INSERTION
JRNL TITL 3 MUTATIONS.
JRNL REF J.MED.CHEM. V. 67 8988 2024
JRNL REFN ISSN 0022-2623
JRNL PMID 38770784
JRNL DOI 10.1021/ACS.JMEDCHEM.4C00227
REMARK 2
REMARK 2 RESOLUTION. 1.62 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.11.8 (24-FEB-2021)
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.62
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.69
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 68.0
REMARK 3 NUMBER OF REFLECTIONS : 66694
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.211
REMARK 3 R VALUE (WORKING SET) : 0.209
REMARK 3 FREE R VALUE : 0.243
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.950
REMARK 3 FREE R VALUE TEST SET COUNT : 3301
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.62
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.66
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 22.51
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL
REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1272
REMARK 3 BIN R VALUE (WORKING SET) : 0.3017
REMARK 3 BIN FREE R VALUE : 0.3270
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.65
REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 4842
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 68
REMARK 3 SOLVENT ATOMS : 341
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.59
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 0.05700
REMARK 3 B22 (A**2) : 0.06370
REMARK 3 B33 (A**2) : -0.12070
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : -0.08020
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.260
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.131
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.125
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.130
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.125
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 5019 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 6799 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 1793 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL
REMARK 3 GENERAL PLANES : 834 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 5019 ; 10.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 648 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 4339 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.008
REMARK 3 BOND ANGLES (DEGREES) : 0.88
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.16
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.11
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 8PO4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-JUL-23.
REMARK 100 THE DEPOSITION ID IS D_1292131113.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 25-JAN-19
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : DIAMOND
REMARK 200 BEAMLINE : I03
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.97623
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC
REMARK 200 DATA SCALING SOFTWARE : STARANISO
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 211586
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.621
REMARK 200 RESOLUTION RANGE LOW (A) : 70.450
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 84.5
REMARK 200 DATA REDUNDANCY : 3.200
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.1000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.62
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.69
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 53.06
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: PEG8K, VAPOR DIFFUSION, SITTING DROP,
REMARK 280 TEMPERATURE 293.15K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y,-Z
REMARK 290 3555 X+1/2,Y+1/2,Z
REMARK 290 4555 -X+1/2,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 78.24050
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.59950
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 78.24050
REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 35.59950
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 SER A 695
REMARK 465 GLY A 696
REMARK 465 GLU A 697
REMARK 465 ALA A 698
REMARK 465 PRO A 699
REMARK 465 GLU A 868
REMARK 465 TYR A 869
REMARK 465 HIS A 870
REMARK 465 ALA A 871
REMARK 465 GLU A 872
REMARK 465 GLY A 873
REMARK 465 GLY A 874
REMARK 465 LYS A 875
REMARK 465 GLU A 1015
REMARK 465 TYR A 1016
REMARK 465 LEU A 1017
REMARK 465 ILE A 1018
REMARK 465 PRO A 1019
REMARK 465 GLN A 1020
REMARK 465 GLN A 1021
REMARK 465 GLY A 1022
REMARK 465 SER B 695
REMARK 465 GLY B 696
REMARK 465 GLU B 697
REMARK 465 ALA B 698
REMARK 465 PRO B 699
REMARK 465 ARG B 748
REMARK 465 GLU B 749
REMARK 465 ALA B 750
REMARK 465 THR B 751
REMARK 465 SER B 752
REMARK 465 PRO B 753
REMARK 465 LYS B 754
REMARK 465 GLY B 863
REMARK 465 ALA B 864
REMARK 465 GLU B 865
REMARK 465 GLU B 866
REMARK 465 LYS B 867
REMARK 465 GLU B 868
REMARK 465 TYR B 869
REMARK 465 HIS B 870
REMARK 465 ALA B 871
REMARK 465 GLU B 872
REMARK 465 GLY B 873
REMARK 465 GLY B 874
REMARK 465 LYS B 875
REMARK 465 GLU B 1015
REMARK 465 TYR B 1016
REMARK 465 LEU B 1017
REMARK 465 ILE B 1018
REMARK 465 PRO B 1019
REMARK 465 GLN B 1020
REMARK 465 GLN B 1021
REMARK 465 GLY B 1022
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 THR A 783 -130.62 -129.72
REMARK 500 ASN A 808 -3.61 -164.00
REMARK 500 ARG A 836 -13.79 81.99
REMARK 500 ASP A 837 39.39 -140.25
REMARK 500 MET A1002 10.78 -149.46
REMARK 500 ASP A1003 77.41 -155.39
REMARK 500 THR B 783 -119.91 -121.44
REMARK 500 ARG B 836 -14.85 80.32
REMARK 500 ASP B1003 68.81 -150.90
REMARK 500
REMARK 500 REMARK: NULL
REMARK 525
REMARK 525 SOLVENT
REMARK 525
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE
REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 525
REMARK 525 M RES CSSEQI
REMARK 525 HOH A1382 DISTANCE = 5.88 ANGSTROMS
REMARK 525 HOH A1383 DISTANCE = 8.70 ANGSTROMS
REMARK 525 HOH A1384 DISTANCE = 12.11 ANGSTROMS
REMARK 525 HOH B1357 DISTANCE = 9.17 ANGSTROMS
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 MG B1102 MG
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 ASP B 855 OD2
REMARK 620 2 ATP B1101 O2G 88.8
REMARK 620 3 ATP B1101 O2B 172.3 90.3
REMARK 620 4 ATP B1101 O1A 91.2 96.2 96.5
REMARK 620 N 1 2 3
DBREF 8PO4 A 695 1022 UNP P00533 EGFR_HUMAN 695 1022
DBREF 8PO4 B 695 1022 UNP P00533 EGFR_HUMAN 695 1022
SEQADV 8PO4 ARG A 948 UNP P00533 VAL 948 ENGINEERED MUTATION
SEQADV 8PO4 ARG B 948 UNP P00533 VAL 948 ENGINEERED MUTATION
SEQRES 1 A 328 SER GLY GLU ALA PRO ASN GLN ALA LEU LEU ARG ILE LEU
SEQRES 2 A 328 LYS GLU THR GLU PHE LYS LYS ILE LYS VAL LEU GLY SER
SEQRES 3 A 328 GLY ALA PHE GLY THR VAL TYR LYS GLY LEU TRP ILE PRO
SEQRES 4 A 328 GLU GLY GLU LYS VAL LYS ILE PRO VAL ALA ILE LYS GLU
SEQRES 5 A 328 LEU ARG GLU ALA THR SER PRO LYS ALA ASN LYS GLU ILE
SEQRES 6 A 328 LEU ASP GLU ALA TYR VAL MET ALA SER VAL ASP ASN PRO
SEQRES 7 A 328 HIS VAL CYS ARG LEU LEU GLY ILE CYS LEU THR SER THR
SEQRES 8 A 328 VAL GLN LEU ILE THR GLN LEU MET PRO PHE GLY CYS LEU
SEQRES 9 A 328 LEU ASP TYR VAL ARG GLU HIS LYS ASP ASN ILE GLY SER
SEQRES 10 A 328 GLN TYR LEU LEU ASN TRP CYS VAL GLN ILE ALA LYS GLY
SEQRES 11 A 328 MET ASN TYR LEU GLU ASP ARG ARG LEU VAL HIS ARG ASP
SEQRES 12 A 328 LEU ALA ALA ARG ASN VAL LEU VAL LYS THR PRO GLN HIS
SEQRES 13 A 328 VAL LYS ILE THR ASP PHE GLY LEU ALA LYS LEU LEU GLY
SEQRES 14 A 328 ALA GLU GLU LYS GLU TYR HIS ALA GLU GLY GLY LYS VAL
SEQRES 15 A 328 PRO ILE LYS TRP MET ALA LEU GLU SER ILE LEU HIS ARG
SEQRES 16 A 328 ILE TYR THR HIS GLN SER ASP VAL TRP SER TYR GLY VAL
SEQRES 17 A 328 THR VAL TRP GLU LEU MET THR PHE GLY SER LYS PRO TYR
SEQRES 18 A 328 ASP GLY ILE PRO ALA SER GLU ILE SER SER ILE LEU GLU
SEQRES 19 A 328 LYS GLY GLU ARG LEU PRO GLN PRO PRO ILE CYS THR ILE
SEQRES 20 A 328 ASP VAL TYR MET ILE MET ARG LYS CYS TRP MET ILE ASP
SEQRES 21 A 328 ALA ASP SER ARG PRO LYS PHE ARG GLU LEU ILE ILE GLU
SEQRES 22 A 328 PHE SER LYS MET ALA ARG ASP PRO GLN ARG TYR LEU VAL
SEQRES 23 A 328 ILE GLN GLY ASP GLU ARG MET HIS LEU PRO SER PRO THR
SEQRES 24 A 328 ASP SER ASN PHE TYR ARG ALA LEU MET ASP GLU GLU ASP
SEQRES 25 A 328 MET ASP ASP VAL VAL ASP ALA ASP GLU TYR LEU ILE PRO
SEQRES 26 A 328 GLN GLN GLY
SEQRES 1 B 328 SER GLY GLU ALA PRO ASN GLN ALA LEU LEU ARG ILE LEU
SEQRES 2 B 328 LYS GLU THR GLU PHE LYS LYS ILE LYS VAL LEU GLY SER
SEQRES 3 B 328 GLY ALA PHE GLY THR VAL TYR LYS GLY LEU TRP ILE PRO
SEQRES 4 B 328 GLU GLY GLU LYS VAL LYS ILE PRO VAL ALA ILE LYS GLU
SEQRES 5 B 328 LEU ARG GLU ALA THR SER PRO LYS ALA ASN LYS GLU ILE
SEQRES 6 B 328 LEU ASP GLU ALA TYR VAL MET ALA SER VAL ASP ASN PRO
SEQRES 7 B 328 HIS VAL CYS ARG LEU LEU GLY ILE CYS LEU THR SER THR
SEQRES 8 B 328 VAL GLN LEU ILE THR GLN LEU MET PRO PHE GLY CYS LEU
SEQRES 9 B 328 LEU ASP TYR VAL ARG GLU HIS LYS ASP ASN ILE GLY SER
SEQRES 10 B 328 GLN TYR LEU LEU ASN TRP CYS VAL GLN ILE ALA LYS GLY
SEQRES 11 B 328 MET ASN TYR LEU GLU ASP ARG ARG LEU VAL HIS ARG ASP
SEQRES 12 B 328 LEU ALA ALA ARG ASN VAL LEU VAL LYS THR PRO GLN HIS
SEQRES 13 B 328 VAL LYS ILE THR ASP PHE GLY LEU ALA LYS LEU LEU GLY
SEQRES 14 B 328 ALA GLU GLU LYS GLU TYR HIS ALA GLU GLY GLY LYS VAL
SEQRES 15 B 328 PRO ILE LYS TRP MET ALA LEU GLU SER ILE LEU HIS ARG
SEQRES 16 B 328 ILE TYR THR HIS GLN SER ASP VAL TRP SER TYR GLY VAL
SEQRES 17 B 328 THR VAL TRP GLU LEU MET THR PHE GLY SER LYS PRO TYR
SEQRES 18 B 328 ASP GLY ILE PRO ALA SER GLU ILE SER SER ILE LEU GLU
SEQRES 19 B 328 LYS GLY GLU ARG LEU PRO GLN PRO PRO ILE CYS THR ILE
SEQRES 20 B 328 ASP VAL TYR MET ILE MET ARG LYS CYS TRP MET ILE ASP
SEQRES 21 B 328 ALA ASP SER ARG PRO LYS PHE ARG GLU LEU ILE ILE GLU
SEQRES 22 B 328 PHE SER LYS MET ALA ARG ASP PRO GLN ARG TYR LEU VAL
SEQRES 23 B 328 ILE GLN GLY ASP GLU ARG MET HIS LEU PRO SER PRO THR
SEQRES 24 B 328 ASP SER ASN PHE TYR ARG ALA LEU MET ASP GLU GLU ASP
SEQRES 25 B 328 MET ASP ASP VAL VAL ASP ALA ASP GLU TYR LEU ILE PRO
SEQRES 26 B 328 GLN GLN GLY
HET 26X A1101 36
HET ATP B1101 31
HET MG B1102 1
HETNAM 26X 1-CYCLOPROPYL-~{N}-[3-[1-(1-PROPANOYLAZETIDIN-3-YL)-4-
HETNAM 2 26X PYRIDIN-4-YL-PYRAZOL-3-YL]PHENYL]IMIDAZOLE-4-
HETNAM 3 26X CARBOXAMIDE
HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE
HETNAM MG MAGNESIUM ION
FORMUL 3 26X C27 H27 N7 O2
FORMUL 4 ATP C10 H16 N5 O13 P3
FORMUL 5 MG MG 2+
FORMUL 6 HOH *341(H2 O)
HELIX 1 AA1 ASN A 700 LEU A 704 5 5
HELIX 2 AA2 LYS A 708 THR A 710 5 3
HELIX 3 AA3 SER A 752 ALA A 767 1 16
HELIX 4 AA4 CYS A 797 HIS A 805 1 9
HELIX 5 AA5 GLY A 810 ARG A 831 1 22
HELIX 6 AA6 ALA A 839 ARG A 841 5 3
HELIX 7 AA7 GLY A 857 LEU A 862 1 6
HELIX 8 AA8 PRO A 877 MET A 881 5 5
HELIX 9 AA9 ALA A 882 ARG A 889 1 8
HELIX 10 AB1 THR A 892 THR A 909 1 18
HELIX 11 AB2 PRO A 919 SER A 921 5 3
HELIX 12 AB3 GLU A 922 LYS A 929 1 8
HELIX 13 AB4 THR A 940 TRP A 951 1 12
HELIX 14 AB5 ASP A 954 ARG A 958 5 5
HELIX 15 AB6 LYS A 960 ARG A 973 1 14
HELIX 16 AB7 ASP A 974 TYR A 978 5 5
HELIX 17 AB8 GLY A 983 MET A 987 5 5
HELIX 18 AB9 SER A 991 ASP A 1003 1 13
HELIX 19 AC1 ASN B 700 LEU B 704 5 5
HELIX 20 AC2 LYS B 708 THR B 710 5 3
HELIX 21 AC3 ASN B 756 SER B 768 1 13
HELIX 22 AC4 CYS B 797 HIS B 805 1 9
HELIX 23 AC5 LYS B 806 ILE B 809 5 4
HELIX 24 AC6 GLY B 810 ARG B 831 1 22
HELIX 25 AC7 ALA B 839 ARG B 841 5 3
HELIX 26 AC8 GLY B 857 LEU B 862 1 6
HELIX 27 AC9 PRO B 877 MET B 881 5 5
HELIX 28 AD1 ALA B 882 ARG B 889 1 8
HELIX 29 AD2 THR B 892 THR B 909 1 18
HELIX 30 AD3 PRO B 919 SER B 921 5 3
HELIX 31 AD4 GLU B 922 LYS B 929 1 8
HELIX 32 AD5 THR B 940 TRP B 951 1 12
HELIX 33 AD6 ASP B 954 ARG B 958 5 5
HELIX 34 AD7 LYS B 960 ASP B 974 1 15
HELIX 35 AD8 PRO B 975 TYR B 978 5 4
HELIX 36 AD9 GLY B 983 MET B 987 5 5
HELIX 37 AE1 SER B 991 ASP B 1003 1 13
SHEET 1 AA1 6 ARG A 705 ILE A 706 0
SHEET 2 AA1 6 GLY A 779 LEU A 782 1 O ILE A 780 N ARG A 705
SHEET 3 AA1 6 VAL A 786 THR A 790 -1 O ILE A 789 N GLY A 779
SHEET 4 AA1 6 ILE A 740 LEU A 747 -1 N LEU A 747 O VAL A 786
SHEET 5 AA1 6 GLY A 724 TRP A 731 -1 N TRP A 731 O ILE A 740
SHEET 6 AA1 6 PHE A 712 SER A 720 -1 N ILE A 715 O LYS A 728
SHEET 1 AA2 2 VAL A 843 THR A 847 0
SHEET 2 AA2 2 HIS A 850 ILE A 853 -1 O LYS A 852 N LEU A 844
SHEET 1 AA3 6 ARG B 705 ILE B 706 0
SHEET 2 AA3 6 GLY B 779 LEU B 782 1 O ILE B 780 N ARG B 705
SHEET 3 AA3 6 VAL B 786 THR B 790 -1 O ILE B 789 N GLY B 779
SHEET 4 AA3 6 ILE B 740 GLU B 746 -1 N LYS B 745 O LEU B 788
SHEET 5 AA3 6 THR B 725 TRP B 731 -1 N TRP B 731 O ILE B 740
SHEET 6 AA3 6 PHE B 712 SER B 720 -1 N GLY B 719 O VAL B 726
SHEET 1 AA4 2 VAL B 843 THR B 847 0
SHEET 2 AA4 2 HIS B 850 ILE B 853 -1 O LYS B 852 N LEU B 844
LINK SG CYS A 797 C 26X A1101 1555 1555 1.75
LINK OD2 ASP B 855 MG MG B1102 1555 1555 2.02
LINK O2G ATP B1101 MG MG B1102 1555 1555 1.98
LINK O2B ATP B1101 MG MG B1102 1555 1555 2.01
LINK O1A ATP B1101 MG MG B1102 1555 1555 2.02
CRYST1 156.481 71.199 76.543 90.00 113.00 90.00 C 1 2 1 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.006391 0.000000 0.002713 0.00000
SCALE2 0.000000 0.014045 0.000000 0.00000
SCALE3 0.000000 0.000000 0.014193 0.00000